CellRight Technologies
CellRight Technologies operates as a biotechnology company. The Company specializes in regenerative medicine and develops osteoinductive and wound care scaffolds to improve healing opportunities of defects created by trauma and disease. CellRight Technologies serves customers in the State of Texas.
CellRight Technologies is the industry leader ofosteoinductive matrices and is committed to providing clinicians and their patients with verified osteoinductive implants known to positively impact patient and fusion outcomes. In-vivo and in-vitro testing to verify osteoinductivity is performed post-sterilization by an independent testing laboratory using validated osteoinductivity test methods.
AmnioWorks™
AmnioWorks™ is derived from human amniotic membrane recoverd following a live birth from volunteer donors.
ConCelltrate® 100
ConCelltrate® 100 Inductive Carrier Matrix (ICM) has been histologically proven to contain all five (5) elements of bone formation
Matrix OI®
Matrix OI® is processed using CellRight Technologies® next-generation proprietary BioRinse™
MatrixCellect® 100 DBM Putty
MatrixCellect® 100 is a DBM putty derived from 100% allograft bone.
Conventional Grafts
CellRight Technologies’® proprietary BioRinse™ technology extends to the processing of conventional grafts
Matrix OI® Strips and Blocks
Matrix OI® is a Stem Cell Containment® human scaffold that is processed using CellRight's proprietary BioRinse™ technology.